Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (14,380,083)	$ (3,614,311)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	6,590,960	923,989
Amortization of debt issuance costs	1,097,941	137,825
Equity in loss of unconsolidated investment		57,104
Interest payment added to debt principal		197,980
Stock based compensation expense related to issuance of restricted stock	22,595
Unrealized foreign currency adjustment	1,142,611	174,463
Changes in operating assets and liabilities:
Other assets, net	(1,035,249)	(197,711)
Accounts payable and accrued liabilities	1,712,665	262,567
Due to affiliates	233,322	(905,699)
Net cash used in operating activities	(4,615,238)	(2,963,793)
Cash flows from investing activities:
Purchase of real estate facilities	(188,181,815)	(59,854,218)
Additions to real estate facilities	(1,453,968)	(285,123)
Deposits on acquisitions of real estate facilities	(548,970)	(468,616)
Investments in unconsolidated real estate ventures	(499,202)	(6,079,039)
Net cash used in investing activities	(190,683,955)	(66,686,996)
Cash flows from financing activities:
Proceeds from issuance of secured debt	140,603,502	48,662,500
Repayment of secured debt	(30,608,851)	(14,435,579)
Scheduled principal payments of secured debt	(123,981)
Prepaid debt issuance costs	(58,000)
Debt issuance costs	(1,481,549)	(875,467)
Gross proceeds from issuance of common stock	103,913,984	47,427,658
Proceeds from issuance of noncontrolling interest in our Operating Partnership		7,000
Offering costs	(9,226,517)	(5,916,858)
Distributions paid to common stockholders	(3,667,288)	(453,837)
Distributions paid to noncontrolling interest in our Operating Partnership	(313,722)	(183,869)
Net cash provided by financing activities	199,037,578	74,231,548
Impact of foreign exchange rate changes on cash and restricted cash	(527,600)
Net change in cash, cash equivalents and restricted cash	3,210,785	4,580,759
Cash, cash equivalents and restricted cash, beginning of year	4,580,759
Cash, cash equivalents and restricted cash, end of year	7,791,544	4,580,759
Supplemental disclosures and non-cash transactions:
Cash paid for interest	3,345,009	346,480
Real estate assumed in consolidation of Operating Partnership		16,284,439
Investment in unconsolidated real estate venture assumed in consolidation of Operating Partnership		3,711,918
Debt assumed in consolidation of Operating Partnership		14,237,599
Non controlling interest assumed in connection with consolidation of Operating Partnership		4,574,294
Distribution payable to noncontrolling interest in our Operating Partnership assumed in consolidation of Operating Partnership		22,594
Accounts payable, accrued liabilities and due to affiliate assumed in consolidation of Operating Partnership		1,318,303
Other assets assumed in consolidation of Operating Partnership		153,146
Real estate facilities in due to affiliates		327,646
Debt issuance costs in due to affiliates		68,000
Debt issuance costs in accounts payable and accrued liabilities	26,940
Proceeds from issuance of common stock in accounts payable and accrued liabilities	(211,000)	(350,000)
Offering costs included in accounts payable and accrued liabilities	1,107,528	352,972
Interest rate swap contract in Other Assets	126,864
Foreign currency translation adjustment	191,438
Issuance of shares pursuant to distribution reinvestment plan	2,544,690	329,158
Distributions payable to common stockholders	798,955	202,137
Distributions payable to noncontrolling interests in our Operating Partnership	28,964	23,370
Offering costs in due to affiliates		65,500
Real estate and construction in process in accounts payable and accrued liabilities	553,438	$ 24,127
Deposits on acquisition of real estate facilities in due to affiliates	$ 751,460